What drives the growth of the Preterm Birth and PROM Testing Market?

The market is driven by rising preterm birth rates, advancements in diagnostic technologies, and increased healthcare awareness, especially in emerging markets.

How big is the Preterm Birth and PROM Testing Market?

The global Preterm Birth and PROM Testing Market size was estimated at USD 1.4 Billion in 2023 and is expected to reach USD 3.1 Billion in 2033.

What is the Preterm Birth and PROM Testing Market growth?

The global Preterm Birth and PROM Testing Market is expected to grow at a compound annual growth rate of 8.4%. From 2024 To 2033.

Who are the key companies/players in the Preterm Birth and PROM Testing Market?

Some of the key players in the Preterm Birth and PROM Testing Markets are Qiagen N.V., Hologic, Inc., Cooper Surgical Inc., Abbott, Medixbiochemica, Sera Prognostics, Clinical Innovations, LLC, Biosynex, NX Prenatal, Inc., IQ Products.

Which regions are leading in the Preterm Birth and PROM Testing market?

In 2023, North America led the Preterm Birth and PROM (Premature Rupture of Membranes) Testing Market with a 39.2% share.

What are the key testing methods in the market?

Key testing methods include ultrasound, biochemical markers, uterine monitoring, and molecular diagnostics, which help in early detection and intervention.

How do hospitals contribute to the market?

Hospitals dominate the market as they offer comprehensive care and advanced diagnostic tools, accounting for the largest share of end-users.

What are the challenges in the Preterm Birth and PROM Testing Market?

High costs of advanced diagnostic tests and limited access in low-resource settings are key challenges, along with regulatory hurdles.

What opportunities exist in the market?

Opportunities include expanding into emerging markets, developing affordable point-of-care devices, and leveraging advancements in personalized medicine and predictive diagnostics.

What role do companies play in market growth?

Companies are investing in research and development to improve the accuracy and reliability of testing devices, driving market growth through innovation.

Global Preterm Birth and PROM Testing Market By Test Type (Pelvic exam, Ultrasound, Biochemical Markers(Interleukin (IL)-6, C-Reactive Protein (CRP), IL-1, IL-2, IL-8, TNF-a, Corticotropin-Releasing, Hormone (CRH), Alpha-fetoprotein (AFP)) Uterine Monitoring, Nitazine Test, Ferning Test, Pooling, PAMG-1 Immunoassay, IGFBP Test, Fetal Fibronectin (fFN), Others) By Application (PROM, Preterm Labor, Chorioamnionitis) By ENd-User (Hospitals, Disgnostic Laboratories, Others) Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2024-2033

Published date: Aug 2024
Report ID: 127877
Number of Pages: 216
Format:

- Qiagen N.V.
- Hologic, Inc.
- Cooper Surgical Inc.
- Abbott Laboratories
- Medixbiochemica
- Sera Prognostics
- Clinical Innovations, LLC
- Biosynex
- NX Prenatal, Inc.
- IQ Products
Settings

Related Reports

Our Clients

Inquiry Before Buying

Report ID 127877
Published Date Aug 2024
Rating
- ★★★★★
  
  ★★★★★
- (70)

Buy Now

Trusted by more than 17382 organizations globally

✖

Request a Sample Report

We'll get back to you as quickly as possible

	Single User $6,000 $3,999 USD / per unit save 24%	Multi User $8,000 $5,999 USD / per unit save 28%	Corporate User $10,000 $6,999 USD / per unit save 32%
e-Access
Report Library Access
Data Set (Excel)
Print
Company Profile Library Access
Interactive Dashboard
Free Custumization	No	up to 10 hrs work	up to 30 hrs work
Accessibility	1 User	2-5 User	Unlimited
Analyst Support	up to 20 hrs	up to 40 hrs	up to 50 hrs
Benefit	Up to 20% off on next purchase	Up to 25% off on next purchase	Up to 30% off on next purchase
	Buy Now ($ 3,999)	Buy Now ($ 5,999)	Buy Now ($ 6,999)